Basic Spironolactone Information

• INN (International Nonproprietary Name): Spironolactone.
• Brand Names Available In Canada (English): Aldactone; Aldactazide (combo formulations also listed internationally).
• ATC Code: C03DA01.
• Forms & Dosages: Tablets in 25 mg, 50 mg, 100 mg strengths; oral suspension sometimes compounded by pharmacies; combo tablets with hydrochlorothiazide available.
• Manufacturers In Canada (English): Pfizer is listed among major global suppliers; other manufacturers noted internationally include Searle, Lepetit, Riemser, RPG and regional suppliers.
• Registration Status In Canada (English): Approved for use by Health Canada and marketed in Canada as a prescription medicine.
• OTC / Rx Classification: Prescription Only (Rx) in Canada and most jurisdictions.

Key Findings From Recent Trials

Are you wondering what the latest research says about spironolactone for blood pressure, heart failure and skin conditions?

Major randomized trials and large observational cohort analyses from 2022 to 2025 looked at low‑dose spironolactone for resistant hypertension, adjunctive use in heart‑failure with reduced ejection fraction, and off‑label dermatologic indications such as hormonally driven acne and hirsutism.

Canadian provincial database analyses and multicentre registries showed consistent blood pressure reductions when spironolactone was added at 25–50 mg/day for resistant hypertension.

Across resistant hypertension cohorts the average additional systolic blood pressure reduction was about 8–12 mmHg compared with baseline therapy alone.

When used alongside guideline‑directed medical therapy in selected HFrEF populations, studies reported improved surrogate outcomes such as NYHA class and reductions in natriuretic peptides.

Meta‑analyses through 2024–2025 strengthened evidence for spironolactone in hormonally driven acne and hirsutism, showing clinical improvement after 3–6 months at doses typically between 50 and 200 mg/day.

Safety signals were consistent across studies, with hyperkalemia the most important concern.

Risk of hyperkalemia was highest in patients with estimated GFR below 60 mL/min/1.73 m2 and in those taking concurrent RAAS inhibitors.

Canadian practice recommendations from these analyses support more frequent potassium and creatinine monitoring when spironolactone is used in such higher‑risk patients.

Main Outcomes

How much blood pressure change can be expected when spironolactone is added for resistant hypertension?

Average additional systolic reduction across cohorts was approximately 8–12 mmHg for low‑dose spironolactone (25–50 mg/day).

In HFrEF the drug improved functional surrogates including NYHA class and circulating natriuretic peptide levels when used in addition to ACE inhibitors, ARBs, ARNIs and beta‑blockers.

Safety Observations

What safety issues did recent trials highlight?

Hyperkalemia remained the principal safety concern, particularly with eGFR below 60 mL/min/1.73 m2 or when combined with RAAS inhibitors.

Trials and registries reinforced the need for early and ongoing kidney and electrolyte monitoring in Canadian practice.

Clinical Mechanism Of Action

Want a simple explanation of how spironolactone works?

Spironolactone is a potassium‑sparing diuretic that blocks aldosterone receptors in the kidney.

By preventing aldosterone from promoting sodium retention and potassium excretion, it reduces fluid overload and lowers blood pressure while helping preserve potassium compared with loop or thiazide diuretics.

Now for the scientific breakdown.

Spironolactone is an aldosterone antagonist (ATC: C03DA01) that competitively binds mineralocorticoid receptors in renal collecting ducts and in non‑renal tissues such as the heart, vasculature and sebaceous glands.

This receptor blockade causes natriuresis and reduces aldosterone‑driven fibrosis signalling in the myocardium.

Antagonism at androgen receptors and inhibition of steroidogenesis contribute to antiandrogenic effects useful in acne and hirsutism.

Pharmacokinetics (Brief)

How is spironolactone processed by the body?

After oral dosing spironolactone is metabolized in the liver to active metabolites, most notably canrenone.

Metabolites are eliminated partly via the kidneys, so renal and hepatic impairment affect exposure and dosing decisions.

Tablets are commonly available in 25 mg, 50 mg and 100 mg strengths and product monographs advise dose adjustment in renal or hepatic dysfunction.

Scope Of Approved & Off‑Label Use

Can spironolactone be used for skin, blood pressure, or heart problems in Canada?

Health Canada approves spironolactone as a prescription medication marketed under brand names including Aldactone.

Approved indications per product monographs include oedema related to heart failure, cirrhosis and nephrotic syndrome, treatment and diagnostic use in primary hyperaldosteronism, management of hypokalemia, and adjunctive therapy in heart failure.

Typical adult dosing varies by indication and is detailed in product information; examples include 12.5–50 mg/day for heart failure and 25–200 mg/day for oedema.

Off‑label use is common in Canadian clinical practice, particularly in dermatology.

Spironolactone is widely used off‑label for hormonally driven acne and hirsutism at doses from 50 to 200 mg/day, with at least 3–6 months required to assess effect.

Real‑world Canadian cohorts also show increasing use of low‑dose spironolactone (25–50 mg/day) for resistant hypertension, and clinicians sometimes use it to allow lower doses of loop or thiazide diuretics in cirrhosis.

Dosage Strategy

How should dosing be started and adjusted for different conditions?

Standard tablet strengths available include 25 mg, 50 mg and 100 mg; dosing depends on the indication.

Typical adult ranges are: oedema 25–200 mg/day, hypertension 25–100 mg/day, heart failure adjunct 12.5–50 mg/day, and primary aldosteronism often higher under specialist supervision (100–400 mg/day).

Pediatric dosing is specialist‑driven and weight‑based when used.

Condition‑Specific Dosing Adjustments

What adjustments are needed for the elderly or patients with kidney disease?

Avoid or reduce dose when creatinine clearance is less than 30 mL/min due to hyperkalemia risk.

Elderly patients should start at the lower end of dosing ranges with cautious titration.

For acne or hirsutism a common strategy is to start at 50 mg/day then titrate to effect up to 200 mg/day while discussing contraception in women of childbearing potential.

Monitoring Schedule

When should labs be checked after starting spironolactone?

Obtain baseline potassium and creatinine before starting therapy.

Repeat electrolytes and creatinine within 1–2 weeks after initiation or dose change.

Perform periodic monitoring thereafter and check more frequently if the patient is also taking ACE inhibitors, ARBs, ARNIs, NSAIDs or has CKD.

Safety Protocols

What are the absolute reasons not to use spironolactone?

Absolute contraindications include hyperkalemia, acute renal insufficiency, anuria, Addison’s disease and known hypersensitivity to spironolactone or excipients.

Relative cautions include moderate renal impairment, significant hepatic disease, pregnancy and lactation, elderly status and diabetes with nephropathy.

Adverse Effects (Post‑Market Reports)

Which side effects do Canadian post‑market reports emphasize?

Common side effects are gastrointestinal upset, dizziness, headache and muscle cramps.

Hormonal adverse effects include menstrual irregularities, gynecomastia and, rarely, impotence in men.

Serious adverse events include life‑threatening hyperkalemia and severe renal dysfunction.

Post‑market surveillance in Canada highlights an increased hyperkalemia risk when spironolactone is combined with RAAS inhibitors or when NSAIDs are used concurrently.

Interaction Mapping

Which foods and drugs interact with spironolactone and raise potassium?

High‑potassium foods common in Canadian diets such as bananas, potatoes and orange juice can amplify hyperkalemia risk and should be discussed during counselling.

Salt‑substitute products that contain potassium chloride, available over the counter, are cautioned against for patients on spironolactone.

Drug Combinations Flagged By Health Canada

Which prescription drugs require caution or extra monitoring with spironolactone?

Major interactions include ACE inhibitors, ARBs, ARNIs, direct renin inhibitors, potassium supplements, NSAIDs, trimethoprim and heparin.

Combining spironolactone with other antiandrogenic agents or oestrogen‑containing contraceptives can alter hormonal side‑effect profiles and should be reviewed individually.

Practical Pharmacy Flags

How do community pharmacies in Canada manage interaction risks?

Pharmacy management systems routinely flag major interactions and prompt pharmacists to advise baseline and follow‑up labs.

Provincial stewardship programs and prescriber notes often include monitoring intervals when spironolactone is prescribed alongside RAAS blockers.

Patient Experience Analysis

What do Canadian patients say about taking spironolactone?

Provincial surveys and clinic audits indicate high patient satisfaction when spironolactone is used for acne and hirsutism, typically after 3–6 months of treatment.

Heart‑failure patients often report symptomatic improvement in oedema when spironolactone is part of guideline‑directed therapy.

Adherence can be affected by the need for frequent blood tests and by hormonal side effects.

Forum And Community Pharmacy Trends

What practical concerns appear in online forums and at the counter?

Community discussions highlight price sensitivity and a preference for generic formulations such as Aldactone generics from common manufacturers.

Access to hyperkalemia testing is a concern for patients in rural and remote communities.

Pharmacists commonly counsel women of childbearing potential about contraception and arrange necessary laboratory monitoring.

Distribution & Pricing Landscape

Where can spironolactone be purchased in Canada and how is it priced?

Spironolactone products, including Aldactone and generics from manufacturers listed in product information, are widely available through national chains such as Shoppers, Rexall, Jean Coutu and London Drugs.

Provincial formularies may require prior authorization for specific indications or higher doses under plans like ODB, BC PharmaCare and RAMQ.

Retail and online pharmacies both dispense spironolactone but prescriptions are required for lawful dispensing in Canada.

Provincial drug benefit plans offer variable coverage; private plans differ by policy.

Online Pharmacy Availability & Provincial Restrictions

Can spironolactone be ordered online in Canada?

Online and mail‑order pharmacies operating in Canada dispense spironolactone with a valid prescription and offer delivery and telepharmacy services in some provinces.

Cross‑border purchasing from the U.S. may appear cheaper for some customers but raises regulatory and safety concerns.

Health Canada guidance discourages unregulated importation, and product quality and regulatory compliance should be confirmed before considering foreign suppliers.

Cross‑Border US Comparisons

Is it worth buying spironolactone from the United States?

Retail prices for generic spironolactone in Canada can be higher than some U.S. discount channels, but when provincial subsidies or formularies are applied the cost difference narrows.

Regulatory risks and potential safety issues with importing prescription medicines should be considered seriously.

Alternative Options

What are approved alternatives to spironolactone in Canada?

Key alternatives include eplerenone, a more selective aldosterone antagonist with fewer antiandrogenic effects, and potassium‑sparing diuretics such as amiloride and triamterene.

Thiazide and loop diuretics remain first‑line options for many types of volume control but are not potassium‑sparing.

Pros And Cons Checklist

How do alternatives compare to spironolactone?

Spironolactone pros include proven efficacy for fluid removal, blood pressure lowering and antiandrogenic benefits in dermatology, plus low‑cost generic availability.

Cons include hormonal side effects, hyperkalemia risk and the need for laboratory monitoring.

Eplerenone provides fewer endocrine side effects but is generally more expensive and may be less available in some provinces.

Regulatory Status

How is spironolactone regulated and labelled in Canada?

Spironolactone is an approved prescription drug in Canada with Drug Identification Numbers assigned to marketed products.

Manufacturers must meet Health Canada labelling requirements and participate in post‑market safety reporting.

DIN And Bilingual Labelling Rules

What must appear on Canadian packaging?

Products sold in Canada carry a DIN and bilingual (English/French) labelling as required by regulation.

Packaging typically lists the strength (25/50/100 mg), manufacturer name and storage instructions such as keeping at 20–25°C.

Consolidated FAQ

Can spironolactone be used for acne?

Off‑label use for acne and hirsutism is common in Canada at doses between 50 and 200 mg/day, and a minimum of 3–6 months is usually needed to judge benefit.

Women of childbearing potential require contraception counselling before starting therapy.

Is spironolactone on provincial formularies?

Coverage varies by province and indication; check Ontario Drug Benefit, BC PharmaCare and RAMQ criteria and consult a pharmacist for eligibility details.

How often should potassium be checked?

Check baseline potassium and creatinine, repeat within 1–2 weeks after starting or changing the dose, and then periodically, with more frequent checks for patients on ACE inhibitors, ARBs, ARNIs or those with CKD.

Can I buy spironolactone online without a Canadian prescription?

No; spironolactone is prescription‑only in Canada and should be dispensed with a valid prescriber order.

What about gynecomastia?

Gynecomastia is often reversible after stopping spironolactone but can persist in some cases.

Switching to a more selective agent such as eplerenone may be considered if endocrine effects limit therapy.

Visual Guide

What quick visuals help patients and pharmacy teams?

Suggested infographics include a dosage flowchart showing starting dose, monitoring intervals and titration thresholds.

A provincial coverage map with ODB, BC PharmaCare and RAMQ general criteria helps patients navigate reimbursement.

A purchase‑channel card comparing community pharmacy, online ordering and mail‑order with regulatory flags clarifies safe procurement.

A quick‑check risk poster for hyperkalemia (age, eGFR, RAAS meds, potassium‑rich diet) is useful at the pharmacy counter.

Design notes: include bilingual labels (EN/FR), tablet strength icons (25/50/100 mg), clear DIN placement and icons for lab monitoring and contraindications.

A compact social card that reads “Start → Check K/Cr In 1–2 Weeks → Repeat” works well for patient handouts.

Storage & Transport

How should spironolactone be stored at home and during delivery?

Store tablets at room temperature, 20–25°C, and protect from moisture and light.

Keep medication in the original container with child‑resistant cap where applicable and discard expired medication through pharmacy or municipal hazardous waste programs.

No cold‑chain is required for marketed tablet formulations.

Compounded oral suspensions may have specific refrigeration instructions from the compounding pharmacy and should be stored as labelled.

When shipping to remote or northern communities ensure packaging avoids extreme heat or freezing during transit.

Guidelines For Proper Use

What will a Canadian pharmacist tell you when starting spironolactone?

Pharmacists recommend baseline potassium and creatinine testing, counselling on dietary potassium and OTC interactions like NSAIDs and potassium salts, and contraception counselling for women of childbearing potential.

Pharmacists also discuss hormonal side effects such as menstrual changes and gynecomastia and schedule follow‑up testing as needed.

Community pharmacies commonly offer adherence packaging and telephone or app reminders to support ongoing monitoring.

Provincial Health Authority Guidance

How do provincial formularies influence prescribing and monitoring?

Provincial stewardship programs emphasize appropriate indications such as heart failure and resistant hypertension and provide monitoring algorithms for safe use.

Prior authorization may be required for certain doses or indications and may request documentation of prior therapies or specialist input.

Practical tips include keeping an up‑to‑date medication list, noting the DIN from the medicine label for formulary inquiries, and consulting a local pharmacist about substitution options among generics.

Delivery Across Canada (English)

Alternative Options For Patients

Which alternatives are worth discussing with a prescriber or pharmacist?

Eplerenone is an aldosterone antagonist with fewer endocrine side effects and is an option in heart failure or where gynecomastia is problematic.

Amiloride and triamterene are potassium‑sparing diuretics without direct aldosterone antagonism and may be chosen for specific indications.

Thiazide and loop diuretics remain mainstays for volume control but carry different electrolyte profiles.

Choice depends on the clinical indication, side‑effect tolerance, comorbidities and provincial coverage.

Storage And Disposal Reminder

How should expired spironolactone be disposed of in Canada?

Return unused or expired tablets to a pharmacy take‑back program or follow municipal hazardous waste guidance.

Do not flush medications down the toilet unless the product label specifically instructs doing so.

Practical Ordering Note

How can patients who need spironolactone get it delivered?

In our online pharmacy spironolactone is available by prescription with discreet delivery to Canada in 5–14 days.

Regulatory And Manufacturer Details

Who makes spironolactone and how is it labelled?

Major manufacturers include Pfizer and several international suppliers noted in product information.

Products sold in Canada carry DINs and bilingual labelling and are packaged in blister packs or bottles listing strength and manufacturer.

Concluding Safety Reminders

What are the five quick safety points every patient should remember?

Get baseline potassium and creatinine before starting spironolactone.

Repeat labs within 1–2 weeks after initiation or dose change and monitor periodically thereafter.

Avoid potassium supplements and be cautious with NSAIDs and salt substitutes containing potassium.

Report symptoms such as muscle weakness, palpitations, severe dizziness or reduced urine output promptly.

Discuss contraception if you are a woman of childbearing potential and plan to use spironolactone for acne or hirsutism.